0.9881USDMkt Cap: 41.52M USDP/E: —Last update: 2026-05-21
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Company
Market Cap41.52M USD
Enterprise Value32.12M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.44M USD
Revenue/Share—
Last Price0.9881 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.41
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B4.45
EPS (TTM)-1.27
EPS (Forward)-0.41
52W Range
0.9700100% of range0.9881
52W High0.9881 USD
52W Low0.9700 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-100.49%
ROA-94.13%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.66M USD
CapEx (TTM)—
FCF Margin—
FCF Yield0.82%
Net Debt-9.41M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio82.16
Quick Ratio81.97
Book Value/Sh0.2220 USD
Cash/Share0.2240 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.02M
Float35.03M
Insiders16.71%
Institutions5.03%
Short Interest
Short Ratio2.6d
Short % Float1.07%
Short % Out.0.98%
Shares Short412.25K
Short (prev mo.)437.03K
Technical
SMA 501.045 (-5.4%)
SMA 2001.310 (-24.5%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)50.35K
Avg Vol (10d)97.42K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—